Back to Search
Start Over
High prevalence of pneumocystis pneumonia in interstitial lung disease: a retrospective study.
- Source :
- Infection; Jun2024, Vol. 52 Issue 3, p985-993, 9p
- Publication Year :
- 2024
-
Abstract
- Background: Interstitial lung disease (ILD) is a new risk category for pneumocystis pneumonia (PCP) with a high mortality rate. The definite diagnostic criteria of PCP in ILD patients have not been established until now. The aims of this study were to identify potential risk factors of PCP in patients with ILD, and to evaluate the performance of metagenomic next-generation sequencing (mNGS), CD4 + T cell count, (1–3)-β-d-Glucan (BG) and lactate dehydrogenase (LDH) in the diagnosis of PCP in ILD patients. Methods: This is a retrospective, single-center, case–control study. ILD patients who underwent mNGS from December 2018 to December 2022 were included in the study. Based on the diagnosis criteria of PCP, these patients were divided into PCP-ILD and non-PCP-ILD groups. The potential risk factors for PCP occurrence in ILD patients were analysed via logistic regression. The diagnostic efficacy of mNGS was compared with serological biomarkers. Results: 92 patients with ILD were enrolled, 31 of which had a definite PCP and were assigned to the PCP-ILD group while 61 were to the non-PCP-ILD group. The infection rate of PJ in ILD patients was 33.7% (31/92). The history of glucocorticoid therapy, CD4 + T cell count, BG level and traction bronchiectasis on HRCT were associated with PCP occurrence in ILD patients. LDH level did not reach statistical significance in the logistic regression analysis. mNGS was confirmed as the most accurate test for PCP diagnosis in ILD patients. Conclusion: ILD is a new risk group of PCP with high PCP prevalence. Clinicians should pay close attention to the occurrence of PCP in ILD patients who possess the risk factors of previous glucocorticoid therapy, decreased CD4 + T cell count, increased BG level and absence of traction bronchiectasis on HRCT. mNGS showed the most excellent performance for PCP diagnosis in ILD patients. Peripheral blood CD4 + T cell count and BG level are alternative diagnostic methods for PCP in ILD patients. However, the diagnostic value of serum LDH level was limited in ILD patients. [ABSTRACT FROM AUTHOR]
- Subjects :
- RISK assessment
BRONCHIECTASIS
CD4 lymphocyte count
LOGISTIC regression analysis
INTERSTITIAL lung diseases
LACTATE dehydrogenase
RETROSPECTIVE studies
DESCRIPTIVE statistics
PNEUMOCYSTIS pneumonia
CASE-control method
BETA-glucans
COMPARATIVE studies
SEQUENCE analysis
BIOMARKERS
GLUCOCORTICOIDS
DISEASE risk factors
Subjects
Details
- Language :
- English
- ISSN :
- 03008126
- Volume :
- 52
- Issue :
- 3
- Database :
- Complementary Index
- Journal :
- Infection
- Publication Type :
- Academic Journal
- Accession number :
- 177598415
- Full Text :
- https://doi.org/10.1007/s15010-023-02148-y